Aspirin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial

BACKGROUND: Aspirin has been proposed as a treatment for COVID-19 on the basis of its anti-thrombotic properties. We aimed to evaluate the efficacy and safety of aspirin in patients admitted to hospital with COVID-19. METHODS: In this randomised, controlled, open-label, platform trial, several possi...

Descripción completa

Detalles Bibliográficos
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598213/
https://www.ncbi.nlm.nih.gov/pubmed/34800427
http://dx.doi.org/10.1016/S0140-6736(21)01825-0

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8598213/
https://www.ncbi.nlm.nih.gov/pubmed/34800427
http://dx.doi.org/10.1016/S0140-6736(21)01825-0

Ejemplares similares